125 related articles for article (PubMed ID: 38291143)
1. Research funders must join the fight for equal access to medicines.
Nature; 2024 Feb; 626(7997):7-8. PubMed ID: 38291143
[No Abstract] [Full Text] [Related]
2. Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.
Burci GL; Gostin LO
JAMA; 2017 Feb; 317(5):473-474. PubMed ID: 28170485
[No Abstract] [Full Text] [Related]
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
4. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
5. Trade, TRIPS, and pharmaceuticals.
Smith RD; Correa C; Oh C
Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
[TBL] [Abstract][Full Text] [Related]
6. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
Baker BK
PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
[TBL] [Abstract][Full Text] [Related]
7. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
Sykes AO
Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
[No Abstract] [Full Text] [Related]
8. Flexibilities provided by the Agreement on Trade-Related Aspects of Intellectual Property Rights.
Correa CM
Bull World Health Organ; 2018 Mar; 96(3):148. PubMed ID: 29531410
[No Abstract] [Full Text] [Related]
9. More drugs, less protection.
Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
[No Abstract] [Full Text] [Related]
10. [The world population does not have the drugs it needs. WHO report recommends more stringent control of the drug industry].
Asplund K
Lakartidningen; 2005 Feb 14-20; 102(7):450-1. PubMed ID: 15768693
[No Abstract] [Full Text] [Related]
11. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
McGIVERN L
Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
[TBL] [Abstract][Full Text] [Related]
12. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
13. The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.
Cohen JC; Illingworth P
Dev World Bioeth; 2003 May; 3(1):27-48. PubMed ID: 14577451
[TBL] [Abstract][Full Text] [Related]
14. Some questions about the moral responsibilities of drug companies in developing countries.
Brock DW
Dev World Bioeth; 2001 May; 1(1):33-7. PubMed ID: 12870506
[No Abstract] [Full Text] [Related]
15. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need.
Moran M
PLoS Med; 2005 Sep; 2(9):e302. PubMed ID: 16138789
[TBL] [Abstract][Full Text] [Related]
16. Cautionary Notes on a Global Tiered Pricing Framework for Medicines.
Williams OD; Ooms G; Hill PS
Am J Public Health; 2015 Jul; 105(7):1290-3. PubMed ID: 25973806
[TBL] [Abstract][Full Text] [Related]
17. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
18. Equitable drug access: small-scale manufacturing units can help.
Chikwamba R; Love KR; Bogachev A; Basrai A; Rose T; Randazzo F
Nature; 2022 Sep; 609(7926):245. PubMed ID: 36068302
[No Abstract] [Full Text] [Related]
19. A new era of hope for the world's most neglected diseases.
The
PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790
[TBL] [Abstract][Full Text] [Related]
20. Economic and policy implications of reimportation: a Canadian perspective.
Ward C
Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
